欧洲抗体药物偶联物市场预测至 2030 年 - 区域分析 - 按技术(可裂解接头和不可裂解接头)、应用(血癌、乳腺癌、卵巢癌、尿路上皮癌等)和分销渠道(医院药房、零售)药房和网上药房)
增加开发 ADC 的投资推动欧洲抗体药物偶联物市场
ADC 是肿瘤学领域的游戏规则改变者;这些被广泛接受用于治疗乳腺癌。多家公司正在投入巨额投资来开发新型 ADC。 2022年5月,Evotec SE宣布对Tubulis GmbH进行巨额战略股权投资,用于开发ADC。 Evotec SE 在由 Andera Partners 领投的 Tubliss B 轮融资中投资了 6400 万美元(6000 万美元)。同样,2022年6月,Spirea Limited宣布获得300万美元投资(
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Market Attractiveness
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibody Drug Conjugates Market - Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Growing Strategic Partnerships to Develop Antibody Drug Conjugates
4.1.2 Rising Incidences of Cancer Cases
4.1.3 Increasing FDA Approvals for ADCs
4.2 Market Restraints
4.2.1 High Cost of ADCs Development and Commercialization
4.3 Market Opportunities
4.3.1 Increasing Investments to Develop ADCs
4.4 Market Trends
4.4.1 Escalating Pipeline of ADCs
4.5 Impact Analysis:
5. Antibody Drug Conjugates Market - Europe Market Analysis
5.1 Europe Antibody Drug Conjugates Market Revenue (US$ Mn), 2017 - 2030
6. Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Technology
6.1 Overview
6.2 Europe Antibody Drug Conjugates Market Revenue Share, by Technology 2022 & 2030 (%)
6.3 Cleavable Linker
6.3.1 Overview
6.3.2 Cleavable Linker: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Non-cleavable Linker
6.4.1 Overview
6.4.2 Non-cleavable Linker: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Europe Antibody Drug Conjugates Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Blood Cancer
7.3.1 Overview
7.3.2 Blood Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Breast Cancer
7.4.1 Overview
7.4.2 Breast Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Ovarian Cancer
7.5.1 Overview
7.5.2 Ovarian Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Urothelial Cancer
7.6.1 Overview
7.6.2 Urothelial Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Europe Antibody Drug Conjugates Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Antibody Drug Conjugates Market - Country Analysis
9.1 Europe Antibody Drug Conjugates Market, Revenue and Forecast To 2030
9.1.1 Overview
9.1.2 Europe Antibody Drug Conjugates Market Breakdown, by Country - Revenue (2022) (US$ Million)
9.1.3 Europe: Antibody Drug Conjugates Market, by Country
9.1.3.1 UK
9.1.3.1.1 Overview
9.1.3.1.2 UK: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.1.3 UK: Antibody Drug Conjugates Market, by Technology
9.1.3.1.4 UK: Antibody Drug Conjugates Market, by Application
9.1.3.1.5 UK: Antibody Drug Conjugates Market, by Distribution Channel
9.1.3.2 Germany
9.1.3.2.1 Overview
9.1.3.2.2 Germany: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.2.3 Germany: Antibody Drug Conjugates Market, by Technology
9.1.3.2.4 Germany: Antibody Drug Conjugates Market, by Application
9.1.3.2.5 Germany: Antibody Drug Conjugates Market, by Distribution Channel
9.1.3.3 France
9.1.3.3.1 Overview
9.1.3.3.2 France: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.3.3 France: Antibody Drug Conjugates Market, by Technology
9.1.3.3.4 France: Antibody Drug Conjugates Market, by Application
9.1.3.3.5 France: Antibody Drug Conjugates Market, by Distribution Channel
9.1.3.4 Italy
9.1.3.4.1 Overview
9.1.3.4.2 Italy: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.4.3 Italy: Antibody Drug Conjugates Market, by Technology
9.1.3.4.4 Italy: Antibody Drug Conjugates Market, by Application
9.1.3.4.5 Italy: Antibody Drug Conjugates Market, by Distribution Channel
9.1.3.5 Spain
9.1.3.5.1 Overview
9.1.3.5.2 Spain: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.5.3 Spain: Antibody Drug Conjugates Market, by Technology
9.1.3.5.4 Spain: Antibody Drug Conjugates Market, by Application
9.1.3.5.5 Spain: Antibody Drug Conjugates Market, by Distribution Channel
9.1.3.6 Rest of Europe
9.1.3.6.1 Overview
9.1.3.6.2 Rest of Europe: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.6.3 Rest of Europe: Antibody Drug Conjugates Market, by Technology
9.1.3.6.4 Rest of Europe: Antibody Drug Conjugates Market, by Application
9.1.3.6.5 Rest of Europe: Antibody Drug Conjugates Market, by Distribution Channel
10. Antibody Drug Conjugates Market-Industry Landscape
10.1 Overview
10.2 Organic Growth Strategies
10.2.1 Overview
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Companies' Manufacturing Capacities and Capabilities
11. Company Profiles
11.1 ADC Therapeutics SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Pfizer Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Hoffmann-La Roche Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 ImmunoGen, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 GSK Plc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Gilead Sciences Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 AstraZeneca Plc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Astellas Pharma Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Takeda Pharmaceutical Co Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. Europe Antibody Drug Conjugates Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. List of FDA-Approved ADCs
Table 4. UK: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology
Table 5. UK: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application
Table 6. UK: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 7. Germany: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology
Table 8. Germany: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application
Table 9. Germany: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 10. France: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology
Table 11. France: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application
Table 12. France: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 13. Italy: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology
Table 14. Italy: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application
Table 15. Italy: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 16. Spain: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology
Table 17. Spain: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application
Table 18. Spain: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 19. Rest of Europe: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology
Table 20. Rest of Europe: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application
Table 21. Rest of Europe: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
Table 22. Recent Organic Growth Strategies in Antibody Drug Conjugates Market
Table 23. Recent Inorganic Growth Strategies in the Antibody Drug Conjugates Market
Table 24. Glossary of Terms, Antibody Drug Conjugates Market
List of Figures
Figure 1. Europe Antibody Drug Conjugates Market Segmentation, By Country
Figure 2. Key Insights
Figure 3. Europe Antibody Drug Conjugates Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Antibody Drug Conjugates Market Revenue (US$ Mn), 2017 - 2030
Figure 6. Europe Antibody Drug Conjugates Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 7. Cleavable Linker: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Cleavable Linker: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Drug Conjugates Market Revenue Share, by Application 2022 & 2030 (%)
Figure 10. Blood Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Breast Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Ovarian Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Urothelial Cancer: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Antibody Drug Conjugates Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 16. Hospital Pharmacies: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Retail Pharmacies: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Online Pharmacies: Europe Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Drug Conjugates, by Key Country - Revenue (2022) (US$ Million)
Figure 20. Europe: Antibody Drug Conjugates Market, By Key Countries, 2022 And 2030 (%)
Figure 21. UK: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Germany: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. France: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Italy: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Spain: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Rest of Europe: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)
1. ADC Therapeutics SA
2. Pfizer Inc
3. Hoffmann-La Roche Ltd
4. ImmunoGen, Inc
5. GSK Plc
6. Gilead Sciences Inc
7. AstraZeneca Plc
8. Astellas Pharma Inc
9. Takeda Pharmaceutical Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody drug conjugates market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe antibody drug conjugates market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution